NEW YORK (TheStreet) --Welcome to Don Dion's Daily ETF Winners and Losers. Be sure to stop by each day to get a feel of who's winning and who's losing when it comes to ETFs.
Stryker is falling after announcing its plans to purchase Boston Scientific's ( BSX) neurovascular division for $1.5 billion. Meanwhile, Zimmer is tumbling after reporting its quarterly earnings performance. Although the firm saw earnings climb over the past three months, revenues missed expectations. All prices as of 2:15 PM EST Written by Don Dion in Williamstown, Mass.